GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Price & Overview
OSL:GENT • NO0010748866
Current stock price
The current stock price of GENT.OL is 38 NOK. Today GENT.OL is down by -1.81%. In the past month the price decreased by -14.41%. In the past year, price decreased by -17.39%.
GENT.OL Key Statistics
- Market Cap
- 585.96M
- P/E
- 44.71
- Fwd P/E
- 14.22
- EPS (TTM)
- 0.85
- Dividend Yield
- 1.55%
GENT.OL Stock Performance
GENT.OL Stock Chart
GENT.OL Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to GENT.OL. When comparing the yearly performance of all stocks, GENT.OL is a bad performer in the overall market: 89.85% of all stocks are doing better.
GENT.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL. While GENT.OL has a great health rating, its profitability is only average at the moment.
GENT.OL Earnings
GENT.OL Forecast & Estimates
7 analysts have analysed GENT.OL and the average price target is 64.26 NOK. This implies a price increase of 69.11% is expected in the next year compared to the current price of 38.
For the next year, analysts expect an EPS growth of 204.65% and a revenue growth 19.34% for GENT.OL
GENT.OL Groups
Sector & Classification
GENT.OL Financial Highlights
Over the last trailing twelve months GENT.OL reported a non-GAAP Earnings per Share(EPS) of 0.85. The EPS decreased by -70.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.51% | ||
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| Debt/Equity | 0.09 |
GENT.OL Ownership
GENT.OL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1EL | ESSILORLUXOTTICA | 25.35 | 90.388B | ||
| ESL | ESSILORLUXOTTICA | 25.31 | 90.272B | ||
| EL | ESSILORLUXOTTICA | 25.3 | 90.226B | ||
| CVX | CARVOLIX SA | N/A | 194.9M | ||
| GBT | GUERBET | N/A | 116.288M | ||
| ALCJ | CROSSJECT | 5.88 | 112.549M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 45.781M | ||
| IVN | IVISION TECH SPA | N/A | 13.684M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Oslo Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About GENT.OL
Company Profile
Gentian Diagnostics ASA engages in the research, development, production, marketing, and distribution of immunoassays. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.
Company Info
IPO: 2016-12-14
GENTIAN DIAGNOSTICS ASA
Bjornasveien 5
Moss OSTFOLD NO
Employees: 63
Phone: 4799339905
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you describe the business of GENTIAN DIAGNOSTICS ASA?
Gentian Diagnostics ASA engages in the research, development, production, marketing, and distribution of immunoassays. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.
Can you provide the latest stock price for GENTIAN DIAGNOSTICS ASA?
The current stock price of GENT.OL is 38 NOK. The price decreased by -1.81% in the last trading session.
What is the dividend status of GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a dividend yield of 1.55%. The yearly dividend amount is currently 0.
What is the ChartMill rating of GENTIAN DIAGNOSTICS ASA stock?
GENT.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is GENTIAN DIAGNOSTICS ASA worth?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a market capitalization of 585.96M NOK. This makes GENT.OL a Small Cap stock.
Can you provide the ownership details for GENT stock?
You can find the ownership structure of GENTIAN DIAGNOSTICS ASA (GENT.OL) on the Ownership tab.